Gender-affirming hormone therapy reduces depressive symptoms and psychological distress in transgender people, according to a groundbreaking systematic review of research in the field.
May 24, 2023
0
69
A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation, according ...
May 24, 2023
0
6
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that IL-21, a soluble molecule involved in activating the immune system, can be a potential therapeutic target to help reduce endocrine autoimmune ...
May 17, 2023
0
56
Women who experience more severe hot flashes after menopause are more likely to develop metabolic syndrome and high blood pressure, according to research presented at the 25th European Congress of Endocrinology in Istanbul. ...
May 16, 2023
1
12
Hot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity. A new review published in the Canadian Medical Association Journal (CMAJ ) recommends ...
May 15, 2023
0
11
A US Transgender Survey data found 39% of participants were currently experiencing serious psychological distress, nearly eight times the rate in the US population.
May 10, 2023
0
2
As the population continues to age, there is greater focus on bone health and minimizing fractures to maintain mobility. A new study suggests that various types of hormone therapies not only increase lumbar spine bone mineral ...
May 8, 2023
0
7
For young women who survive breast cancer, a new study offers some reassurance about pregnancy: Pausing hormonal therapy to have a baby does not raise the risk of a cancer recurrence, at least in the shorter term.
May 4, 2023
0
4
A new research perspective was published in Oncotarget's, titled "Crossroads: the role of biomarkers in the management of lumps in the breast."
May 2, 2023
0
12
The addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival for men with oligometastatic prostate ...
Apr 13, 2023
0
17
